Metraipolis › archive › dc_862e2ac47aea

Advances in post-translational and epigenetic modification of hyperuricemia-to-gout progression: mechanisms and therapeutic targets — Europe PMC PMID:42293766

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42293766
DOI
10.3389/fcell.2026.1749194
License (as archived)
solo-consultazione
Archived
2026-11-01T02:18:57.287Z
SHA-256 of the archived text
b2e0ac05e03d10d3f86d882ec220aa516739d848ca8e6c3ae3b9fad2454bcb27
Stable URL of this page
https://metraipolis.com/documento/dc_862e2ac47aea

How to cite

Advances in post-translational and epigenetic modification of hyperuricemia-to-gout progression: mechanisms and therapeutic targets — Europe PMC PMID:42293766 — Europe PMC (en), https://europepmc.org/article/MED/42293766 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_862e2ac47aea (Metraipolis archive dc_862e2ac47aea, sha256 b2e0ac05e03d10d3f86d882ec220aa516739d848ca8e6c3ae3b9fad2454bcb27)
BibTeX
@misc{dc862e2ac47aea,
  title = {Advances in post-translational and epigenetic modification of hyperuricemia-to-gout progression: mechanisms and therapeutic targets — Europe PMC PMID:42293766},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42293766},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_862e2ac47aea; sha256 b2e0ac05e03d10d3f86d882ec220aa516739d848ca8e6c3ae3b9fad2454bcb27},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42293766. Agents can read the archived copy with the MCP tool read_document.